Global Premature Ejaculation Drug Industry is dominated by companies such as Eli Lily, Absorption Pharmaceuticals, Bayer, GlaxoSmithKline, Emcure Futura Medical, among others, which are mentioned in the report.
The report also contains the details of premature ejaculation drug sales, prices, revenue, market share, and gross margin.
It contains 15 chapters that display the Global Premature Ejaculation Treatment market, such as:
- Premature Ejaculation Treatment Introduction, product scope, and market overview, opportunities, risk, share and driving force
- Analysis of the top drug manufacturers of Premature Ejaculation Treatment, along with their with sales, revenue, and price
- Competitive situation among the top drug manufacturers
- Analysis of the key regions, sales, revenue and market share
- Analysis of market forecast according to regions, type and application, sales and revenue
One can purchase the research report at Market Reports online.
The market segment of Global Premature Ejaculation Treatment by regions covers North America, Europe, Asia-Pacific, South America, Middle East and Africa.
Premature Ejaculation, shortly known as PE, is one of the sexual dysfunctions in men characterized by early ejaculation. In this condition, a man ejaculates very soon during sexual activity. They ejaculate either on minimal sexual stimulation or soon after vaginal penetration. Priligy (Dapoxetine) is one of the most commonly prescribed medications for premature ejaculation. The exact mechanism of the drug is unknown but it is presumed that Dapoxetine, an antidepressant, works on a brain chemical to delay ejaculation.
